Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001232524-24-000086
Filing Date
2024-11-07
Accepted
2024-11-07 07:32:06
Documents
87
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q jazz-20240930.htm   iXBRL 10-Q 1755412
2 CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) jazzq32024ex311.htm EX-31.1 10266
3 CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) jazzq32024ex312.htm EX-31.2 10334
4 CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 jazzq32024ex321.htm EX-32.1 7032
  Complete submission text file 0001232524-24-000086.txt   8936128

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jazz-20240930.xsd EX-101.SCH 58204
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jazz-20240930_cal.xml EX-101.CAL 101404
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jazz-20240930_def.xml EX-101.DEF 318844
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jazz-20240930_lab.xml EX-101.LAB 638303
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jazz-20240930_pre.xml EX-101.PRE 483908
90 EXTRACTED XBRL INSTANCE DOCUMENT jazz-20240930_htm.xml XML 1442764
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33500 | Film No.: 241433195
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)